These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2579631)

  • 1. An antimelanoma monoclonal antibody and the histopathology of uveal melanomas.
    Folberg R; Donoso LA; Atkinson BF; Ernst CS; Herlyn M; Arbizo VV
    Arch Ophthalmol; 1985 Feb; 103(2):275-9. PubMed ID: 2579631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human uveal melanoma expresses NG2 immunoreactivity.
    Li Y; Madigan MC; Lai K; Conway RM; Billson FA; Crouch R; Allen BJ
    Br J Ophthalmol; 2003 May; 87(5):629-32. PubMed ID: 12714409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of melanoma-associated antigens in uveal melanomas.
    van der Pol JP; Jager MJ; de Wolff-Rouendaal D; Ringens PJ; Vennegoor C; Ruiter DJ
    Curr Eye Res; 1987 Jun; 6(6):757-65. PubMed ID: 3608565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
    Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
    Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1362-7. PubMed ID: 3744725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to uveal melanoma.
    Damato BE; Campbell AM; McGuire BJ; Lee WR; Foulds WS
    Eye (Lond); 1987; 1 ( Pt 6)():686-90. PubMed ID: 3454763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating lymphocytes and antigen expression in uveal melanoma.
    Meecham WJ; Char DH; Kaleta-Michaels S
    Ophthalmic Res; 1992; 24(1):20-6. PubMed ID: 1608588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors.
    Berrington AJ; Jimbow K; Haines DM
    Vet Pathol; 1994 Jul; 31(4):455-61. PubMed ID: 7941235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic and cellular heterogeneity of primary uveal melanomas.
    Folberg R
    Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
    Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
    Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of MoAb HMSA-3 and HMSA-4 against human melanoma melanosomes and their reactivities on formalin-fixed melanoma tissues.
    Maeda K; Yamana K; Jimbow K
    J Invest Dermatol; 1987 Dec; 89(6):588-93. PubMed ID: 3680982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma.
    Chowers I; Folberg R; Livni N; Pe'er J
    Ophthalmology; 2001 Feb; 108(2):367-71. PubMed ID: 11158814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
    Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
    Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of ocular melanoma with cutaneous melanoma antibodies.
    Bomanji J; Garner A; Prasad J; Albert DM; Hungerford JL; Granowska M; Britton KE
    Br J Ophthalmol; 1987 Sep; 71(9):647-50. PubMed ID: 3311140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors.
    Atkinson B; Ernst CS; Ghrist BF; Ross AH; Clark WH; Herlyn M; Herlyn D; Maul G; Steplewski Z; Koprowski H
    Hybridoma; 1985; 4(3):243-55. PubMed ID: 4043988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.